Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment.

British journal of clinical pharmacology - 1 Aug 2003

Shiran M R, Chowdry J, Rostami-Hodjegan A, Ellis S W, Lennard M S, Iqbal M Z, Lagundoye O, Seivewright N, Tucker G T

Abstract excerpt

AIMS: To assess CYP2D6 activity and genotype in a group of patients undergoing methadone maintenance treatment (MMT). METHODS: Blood samples from 34 MMT patients were genotyped by a polymerase chain reaction-based method, and results were compared with CYP2D6 phenotype (n = 28), as measured by th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP2D6
Share to Homozygote
Share to Methadone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Narcotics

Share to Opioid-Related Disorders

Share to Polymerase Chain Reaction

Share to Regression Analysis

Share to Urinalysis

Source

Open in PubMed Open full text

Identifiers

PMID: 12895196
DOI: 10.1046/j.1365-2125.2003.01851.x
PMCID: PMC1884285

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12895196-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment.PMID 12895196Read ↗

Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizers.Semantic proximity Read ↗

Genotype and phenotype of cytochrome P450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome.Semantic proximity Read ↗

Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships.Semantic proximity Read ↗

Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadone.Semantic proximity Read ↗

Cytochrome P450 2D6 genotype and methadone steady-state concentrations.Semantic proximity Read ↗

CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population.Semantic proximity Read ↗

Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL studySemantic proximity Read ↗

The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry.Semantic proximity Read ↗

Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects.Semantic proximity Read ↗

The Use of the Methadone/Metabolite Ratio (MMR) to Identify an Individual Metabolic Phenotype and Assess Risks of Poor Response and Adverse Effects: Towards Scientific Methadone Dosing.Semantic proximity Read ↗

CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication.Semantic proximity Read ↗

CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.